ELIQUENT Life Sciences Appoints Shelley Gandhi to Strengthen Pharmacovigilance and Risk Management Services
Shelley Gandhi ● Photo Credit: ELIQUENT
WASHINGTON, Nov. 4, 2024 (VSNewsNetwork.com) – Regulatory consulting firm ELIQUENT Life Sciences has announced the addition of pharmacovigilance (PV) specialist Shelley Gandhi to support its expanding PV and risk management services. According to the company, Gandhi, who has over three decades of experience in the field, will work on enhancing ELIQUENT’s pharmacovigilance solutions for clients navigating regulatory requirements.
Gandhi previously held senior roles at the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) and served as a representative on the European Medicines Agency’s EudraVigilance Expert Working Group. In this role, she contributed to developing systems for monitoring adverse reactions to medicines in Europe.
“Shelley’s firsthand knowledge of regulatory expectations and her proficiency in navigating complex regulatory challenges will be instrumental in expanding ELIQUENT’s pharmacovigilance solutions to meet the growing global demand for comprehensive safety and risk management across diverse markets”, said Tim Dietlin, ELIQUENT’s Chief Executive Officer.
For further details on ELIQUENT’s services, visit www.eliquent.com.
Source: ELIQUENT Life Sciences
@VSNewsNetwork
@VSNewsNetwork
